Form 8-K · Current Report · Filed 2024-02-16
GE HealthCare Commences Secondary Offering of 13,000,000 Shares
GE HealthCare Technologies Inc. announced the commencement of a secondary underwritten public offering of 13,000,000 shares of its common stock. The offering price is set at $82.25 per share. Notably, GE HealthCare itself is not selling any shares and will not receive any proceeds from the sale of these shares. Instead, General Electric Company is expected to exchange the shares for its held indebtedness prior to the closing of the offering. Morgan Stanley & Co. LLC, as the selling stockholder, intends to sell the shares to the underwriters after the debt-for-equity exchange. GE HealthCare filed a shelf registration statement with the SEC for the offering. This press release does not constitute an offer to sell or a solicitation of an offer to buy securities.
- Filer
- Ge Healthcare Technologies Inc. GEHC · NASDAQ
- Filed
- Accession
- 0001193125-24-038569
- CIK
- 0001932393
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Other Events
Financial Statements and Exhibits
Market reaction
Close before filing
$85.63
Next session
+0.9%
Since filing
-20.6%
Latest close
$68.02
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from GEHC reporting the same item, with the next session's move:
Exhibits (3)
About Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc. is a prominent player in the healthcare industry, focused on providing transformative medical technology and diagnostic solutions. Specializing in imaging, monitoring, and diagnostic equipment, the company plays a crucial role in enhancing clinical outcomes, improving patient care, and driving medical technology innovations. Ge Healthcare Technologies Inc. is recognized for its advancements in medical imaging systems, including MRI, CT, and ultrasound technologies, which aid in early disease detection and treatment planning. In addition to its hardware innovations, the company is actively involved in digital healthcare solutions, employing data analytics and AI to support precise diagnoses and personalized medicine. The impact of Ge Healthcare Technologies extends across various healthcare sectors, including hospitals, clinics, and research institutions, underscoring its importance in advancing clinical capabilities and operational efficiencies within the healthcare system. Ge Healthcare Technologies Inc. maintains a strategic presence in global markets, bolstering healthcare infrastructure and supporting public health initiatives. By continuously striving to innovate and improve healthcare delivery, it remains a significant entity within the broader medical technology and life sciences industry, contributing to the future of healthcare.
Never miss another GEHC filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.